幽门螺杆菌
医学
内科学
回顾性队列研究
逻辑回归
胃肠病学
多元分析
抗药性
抗生素
幽门螺杆菌感染
抗生素耐药性
临床疗效
铋
螺杆菌感染
药物治疗
克拉霉素
螺杆菌
呼吸试验
螺旋藻科
左氧氟沙星
联合疗法
作者
Xiaomin Wang,Liyan Dong,Guo Lin,Zhixin Jiang,Yue Hou,Wenxiu Zhang,Ying Ma,Yongguo Zhang,Jiang Chen,Xingshun Qi
标识
DOI:10.1080/17512433.2026.2749579
摘要
Background Increasing antibiotic resistance has undermined Helicobacter pylori eradication. Despite a low resistance to minocycline, clinical evidence for minocycline-containing bismuth quadruple therapy (MCQT) limited. This retrospective study aimed to evaluate the clinical efficacy of MCQT.Research design and methods Patients who had Helicobacter pylori infection by 13C-urea breath testing at our department from October 2024 to July 2025 were screened. They were classified into MCQT (minocycline-amoxicillin-acid-inhibitors-bismuth [MAAB], minocycline-clarithromycin-acid-inhibitors-bismuth [MCAB], and minocycline-levofloxacin-acid-inhibitors-bismuth [MLAB]) and non-MCQT (amoxicillin-clarithromycin-acid-inhibitors-bismuth [ACAB] and amoxicillin-levofloxacin-acid-inhibitors-bismuth [ALAB]). Four comparisons (MAAB vs. ACAB, MCAB vs. ACAB, MLAB vs. ALAB, and MAAB vs. ALAB) were separately performed in treatment‑naïve and treatment‑experienced patients. Logistic regression analyses were used to identify the influence factors.Results Overall, 687 treatment-naïve and 92 treatment-experienced Helicobacter pylori patients were included. MAAB demonstrated significantly higher eradication rates than ACAB in both groups (P = 0.020, P = 0.016), with no significant differences in other comparisons. Multivariate logistic regression analysis indicated that female was independently associated with a higher eradication rate in treatment-naïve patients in three comparisons (MAAB vs. ACAB, P = 0.021; MCAB vs. ACAB, P = 0.009; MAAB vs. ALAB, P = 0.043).Conclusions MCQT achieve favorable Helicobacter pylori eradication rates in both treatment-naïve and treatment-experienced patients, and MAAB demonstrates a significantly higher eradication rate than ACAB.
科研通智能强力驱动
Strongly Powered by AbleSci AI